Bafna Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 ,inter alia, to consider and approve the Un-Audited Financial ....
BAFNAPH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bafna Pharmaceuticals has informed the stock exchanges that its Board of Directors will meet on August 12, 2025 to consider and approve the Unaudited Financial Results for the quarter ended June 30, 2025 (Q1 FY26). The company has also notified that the trading window for designated persons and their immediate relatives is closed from July 1, 2025 to August 14, 2025 in line with insider trading rules. No financial numbers or business details are disclosed in this filing — it is purely a procedural intimation ahead of the results announcement.
Investors should watch for the Q1 FY26 results on or after August 12, 2025. The trading window closure is a routine compliance measure and not a signal about performance.